SAGE THERAPEUTICS INC (SAGE) Stock Analyst Earnings Estimates
NASDAQ:SAGE - Nasdaq - US78667J1088 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.7M 22.22% | 86.455M 1,022.79% | 41.243M -52.30% | 83.969M 103.60% | 120.02M 42.93% | 158.71M 32.24% | 192M 20.98% | 233.65M 21.69% | 243.67M 4.29% | 249.53M 2.40% | 257.14M 3.05% | |
| EBITDA YoY % growth | -545.9M -19.53% | -545.07M 0.15% | -409.485M 24.87% | -245.645M 40.01% | -208.584M 15.09% | -120.308M 42.32% | -63.597M 47.14% | -18.36M 71.13% | 46.614M 353.89% | N/A | N/A | |
| EBIT YoY % growth | -547M -18.68% | -546.463M 0.10% | -410.516M 24.88% | -246.86M 39.87% | -215.671M 12.63% | -175.659M 18.55% | -122.397M 30.32% | -70.572M 42.34% | -80.399M -13.92% | -84.459M -5.05% | 23.584M 127.92% | |
| Operating Margin | -7,103.90% | -632.08% | -995.36% | -293.99% | -179.70% | -110.68% | -63.75% | -30.20% | -32.99% | -33.85% | 9.17% | |
| EPS YoY % growth | -8.98 -15.13% | -10.31 -14.81% | -6.59 36.08% | -3.67 44.26% | -2.94 20.06% | -2.00 31.89% | -1.35 32.30% | -0.65 51.98% | -1.98 -204.31% | -1.95 1.55% | 0.22 111.52% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.84 45.07% | -0.81 48.23% | -0.78 22.84% | -0.76 3.81% | -0.78 7.77% | -0.77 4.64% |
| Revenue Q2Q % growth | 24.752M 108.51% | 26.922M 110.08% | 25.458M 81.03% | 27.489M -13.17% | 29.682M 19.92% | 32.589M 21.05% |
| EBITDA Q2Q % growth | -62.091M 38.10% | -61.114M 22.94% | -52.032M 22.14% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -57.582M 43.10% | -56.388M 29.81% | -55.767M 16.69% | -59.129M -8.99% | -59.568M -3.45% | -59.225M -5.03% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.79 53.53% | -0.97 | 0.18 | 18.46% |
| Q1 2025 Q2Q % growth | -1.01 43.89% | -1.02 | 0.01 | 0.49% |
| Q4 2024 Q2Q % growth | -1.56 13.33% | -1.54 | -0.02 | -1.61% |
| Q3 2024 Q2Q % growth | -1.53 54.60% | -1.56 | 0.03 | 2.18% |
| Q2 2024 Q2Q % growth | -1.70 36.57% | -1.69 | -0.01 | -0.48% |
| Q1 2024 Q2Q % growth | -1.80 26.83% | -1.68 | -0.12 | -7.14% |
| Q4 2023 Q2Q % growth | -1.80 27.13% | -1.30 | -0.50 | -38.16% |
| Q3 2023 Q2Q % growth | -3.37 -45.89% | -2.79 | -0.58 | -21.00% |
| Q2 2023 Q2Q % growth | -2.68 -25.82% | -2.60 | -0.08 | -2.89% |
| Q1 2023 Q2Q % growth | -2.46 -18.84% | -2.55 | 0.09 | 3.37% |
| Q4 2022 Q2Q % growth | -2.47 -16.51% | -2.44 | -0.03 | -1.43% |
| Q3 2022 Q2Q % growth | -2.31 -4.52% | -2.25 | -0.06 | -2.60% |
| Q2 2022 Q2Q % growth | -2.13 -16.39% | -2.20 | 0.07 | 2.98% |
| Q1 2022 Q2Q % growth | -2.07 -26.22% | -2.08 | 0.01 | 0.35% |
| Q4 2021 Q2Q % growth | -2.12 -111.65% | -2.21 | 0.09 | 4.29% |
| Q3 2021 Q2Q % growth | -2.21 -8.87% | -1.89 | -0.32 | -16.91% |
| Q2 2021 Q2Q % growth | -1.83 12.02% | -1.73 | -0.10 | -5.95% |
| Q1 2021 Q2Q % growth | -1.64 32.79% | -1.95 | 0.31 | 15.77% |
| Q4 2020 Q2Q % growth | 18.19 659.69% | -0.36 | 18.55 | 5,163.12% |
| Q3 2020 Q2Q % growth | -2.03 41.67% | -2.43 | 0.40 | 16.61% |
| Q2 2020 Q2Q % growth | -2.08 36.59% | -2.71 | 0.63 | 23.32% |
| Q1 2020 Q2Q % growth | -2.44 27.60% | -3.20 | 0.76 | 23.77% |
| Q4 2019 Q2Q % growth | -3.25 | -3.68 | 0.43 | 11.63% |
| Q3 2019 Q2Q % growth | -3.48 | -3.43 | -0.05 | -1.41% |
| Q2 2019 Q2Q % growth | -3.28 | -3.40 | 0.12 | 3.47% |
| Q1 2019 Q2Q % growth | -3.37 | -3.31 | -0.06 | -1.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 31.66M 265.84% | 17.099M | 14.561M | 85.16% |
| Q1 2025 Q2Q % growth | 14.063M 77.97% | 14.424M | -361K | -2.50% |
| Q4 2024 Q2Q % growth | 12.815M -83.56% | 14.729M | -1.914M | -12.99% |
| Q3 2024 Q2Q % growth | 11.871M 337.08% | 11.018M | 853K | 7.74% |
| Q2 2024 Q2Q % growth | 8.654M 250.36% | 9.025M | -371K | -4.11% |
| Q1 2024 Q2Q % growth | 7.902M 139.89% | 5.891M | 2.011M | 34.14% |
| Q4 2023 Q2Q % growth | 77.972M 2,588.69% | 62.197M | 15.775M | 25.36% |
| Q3 2023 Q2Q % growth | 2.716M 59.76% | 4.71M | -1.994M | -42.34% |
| Q2 2023 Q2Q % growth | 2.47M 64.67% | 3.002M | -532K | -17.72% |
| Q1 2023 Q2Q % growth | 3.294M 105.88% | 2.454M | 840K | 34.23% |
| Q4 2022 Q2Q % growth | 2.9M 81.25% | 1.977M | 923K | 46.69% |
| Q3 2022 Q2Q % growth | 1.7M 21.43% | 1.672M | 28K | 1.67% |
| Q2 2022 Q2Q % growth | 1.5M -6.25% | 1.797M | -297K | -16.53% |
| Q1 2022 Q2Q % growth | 1.6M | 3.271M | -1.671M | -51.09% |
| Q4 2021 Q2Q % growth | 1.6M -99.86% | 2.014M | -414K | -20.56% |
| Q3 2021 Q2Q % growth | 1.4M -12.50% | 1.998M | -598K | -29.93% |
| Q2 2021 Q2Q % growth | 1.6M 45.45% | 2.048M | -448K | -21.88% |
| Q1 2021 Q2Q % growth | 1.6M -30.43% | 2.043M | -443K | -21.68% |
| Q4 2020 Q2Q % growth | 1.109B 55,360.00% | 56.447M | 1.053B | 1,865.03% |
| Q3 2020 Q2Q % growth | 1.6M -55.56% | 1.903M | -303K | -15.92% |
| Q2 2020 Q2Q % growth | 1.1M 22.22% | 905.281K | 194.719K | 21.51% |
| Q1 2020 Q2Q % growth | 2.3M 360.00% | 2.852M | -552K | -19.35% |
| Q4 2019 Q2Q % growth | 2M | 3.756M | -1.756M | -46.75% |
| Q3 2019 Q2Q % growth | 3.6M | 3.674M | -74K | -2.01% |
| Q2 2019 Q2Q % growth | 900K | 262.364K | 637.636K | 243.03% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.96% | -0.7% | 0% | -2.57% |
| Revenue | 0.49% | 2.68% | 0.93% | -0.06% |